GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 24,212.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 11,710.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 35,923.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -35,823.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | 297.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -35,323.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -518.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -35,323.8% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -34,807.1% | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.